We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPYM
126
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$3.82M 0.04%
97,110
+9,385
+11% +$365K
VRTX icon
127
Vertex Pharmaceuticals
VRTX
$126B
$3.81M 0.04%
13,996
+8,388
+150% +$2.31M
BKNG icon
128
Booking.com
BKNG
$161B
$3.81M 0.04%
55,625
+5,350
+11% +$376K
MNST icon
129
Monster Beverage
MNST
$88.5B
$3.78M 0.04%
94,214
+72,912
+342% +$2.88M
USMV icon
130
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
$3.77M 0.04%
+59,090
New +$3.75M
BJ icon
131
BJs Wholesale Club
BJ
$12.3B
$3.72M 0.04%
89,599
+51,051
+132% +$2.11M
VV icon
132
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$3.71M 0.04%
23,738
-32,340
-58% -$4.99M
TXRH icon
133
Texas Roadhouse
TXRH
$13.7B
$3.69M 0.04%
60,747
+40,745
+204% +$2.39M
MMM icon
134
3M
MMM
$94.3B
$3.67M 0.04%
27,376
+12,769
+87% +$1.72M
NVRO
135
DELISTED
NEVRO CORP.
NVRO
$3.66M 0.04%
26,270
+19,892
+312% +$2.66M
MASI
136
DELISTED
Masimo
MASI
$3.65M 0.04%
15,451
-12,749
-45% -$2.86M
AMED
137
DELISTED
Amedisys
AMED
$3.64M 0.04%
15,383
+2,995
+24% +$681K
FXO icon
138
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$3.62M 0.04%
142,841
+71,986
+102% +$1.88M
TMO icon
139
Thermo Fisher Scientific
TMO
$220B
$3.6M 0.04%
8,159
+152
+2% +$62.8K
PFGC icon
140
Performance Food Group
PFGC
$18B
$3.6M 0.04%
103,976
+93,148
+860% +$3M
TRUP icon
141
Trupanion
TRUP
$1.18B
$3.6M 0.04%
45,558
+40,737
+845% +$2.44M
MDLZ icon
142
Mondelez International
MDLZ
$79.9B
$3.58M 0.04%
62,320
+21,576
+53% +$1.2M
SOXL icon
143
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$23.8B
$3.57M 0.04%
211,515
-2,103,705
-91% -$32.6M
BA icon
144
Boeing
BA
$185B
$3.57M 0.04%
21,605
+10,894
+102% +$1.86M
GILD icon
145
Gilead Sciences
GILD
$165B
$3.57M 0.04%
56,452
+25,952
+85% +$1.8M
CCI icon
146
Crown Castle
CCI
$32.2B
$3.56M 0.04%
21,396
+11,649
+120% +$1.92M
SMTC icon
147
Semtech
SMTC
$13B
$3.54M 0.04%
66,867
+46,614
+230% +$2.62M
NDSN icon
148
Nordson
NDSN
$17.3B
$3.54M 0.04%
18,437
+6,211
+51% +$1.2M
SPXL icon
149
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.42B
$3.54M 0.04%
67,115
-17,181
-20% -$884K
AVNT icon
150
Avient
AVNT
$4.19B
$3.52M 0.04%
133,008
+102,825
+341% +$2.68M

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.